QuantXR™ is our powerful AI engine that drives all our medical imaging solutions. At its core, it comprises a suite of specialized artificial intelligence models focused on quantitative measurement and assessment of medical images.

Our engine is designed to extract precise, clinically relevant measurements and insights from medical images, enabling healthcare providers to make more informed decisions.

Looking ahead, we are developing an open API that will integrate with frontier large language and vision-language models, further enhancing assessment capabilities and improving accuracy across our entire solution portfolio.

OccuChestXR™ addresses a critical gap in occupational health screening. Currently, over 150,000 employees and workers in Hong Kong are expected to undergo a chest X-ray as part of their pre-employment health check, yet these examinations often provide only basic assessments without evaluating cardiovascular disease risk.

Our solution seamlessly integrates with existing clinical workflows, requiring no additional tests or changes to current practices, while providing valuable cardiovascular risk insights from routine chest X-rays.

By empowering both employees and clinics with these additional insights, we enable more informed decisions about health management and preventive care, potentially identifying cardiovascular risks before they become serious health issues.

StandardViewXR™ addresses a critical challenge in big data research and medical imaging: the need for accurate image curation and annotation. Current practices in tagging X-ray images and series are often error-prone due to insufficient quality assurance measures.

Our solution employs advanced image-level analysis, independent of DICOM metadata, to accurately detect and classify standard views and imaging targets in X-ray examinations, ensuring reliable data organization for research and clinical applications.

By providing accurate, automated classification of X-ray views and targets, StandardViewXR™ significantly improves the quality and reliability of medical imaging datasets, enabling more robust research outcomes and better clinical decision support.

We are excited to announce that Detect Medical Technology Limited has officially joined the Hong Kong Science and Technology Park (HKSTP) Incubation Programme. This milestone marks a significant step forward in our mission to advance AI-powered medical imaging solutions that empower healthcare providers and individuals alike.

Joining the HKSTP Incubation Programme provides us with invaluable access to world-class facilities, expert mentorship, and a vibrant innovation ecosystem. The programme's comprehensive support—including funding, R&D resources, investor matching, and networking opportunities—will accelerate our product development and commercialization efforts. HKSTP's commitment to nurturing startups in life and health technologies aligns perfectly with our vision of transforming medical imaging into a powerful digital health tool.

We thank HKSTP for their support and are excited to embark on this journey to revolutionize healthcare through AI and medical imaging.

We are proud to announce that Detect Medical Technology will be presenting our latest research at the American Heart Association (AHA) Scientific Sessions 2024, the world's premier cardiology conference. The event will take place from November 16 to 18, 2024, at the McCormick Place Convention Center in Chicago, Illinois.

Our abstract, featured in the official AHA journal, highlights the innovative AI-driven tools we are developing to extract clinically relevant cardiovascular insights from routine medical imaging. This work aims to enhance early detection and risk assessment of chronic cardiovascular diseases, bridging the gap between traditional clinical care and digital health solutions.

Participating in AHA Scientific Sessions offers us a unique platform to share our advancements with leading cardiologists, researchers, and healthcare professionals from around the globe. We look forward to engaging with the cardiovascular community, exploring collaborations, and contributing to the future of heart health through AI and medical imaging.

Find out more about our publication here.

We are pleased to announce that Detect Medical Technology was selected to exhibit our latest innovations at the Hong Kong International Biotechnology Convention 2024 (BIOHK 2024) as part of the Cyberport community.

At BIOHK 2024, we showcased our AI-powered medical imaging solutions designed to bridge the gap between clinical care and digital health. Our technology empowers healthcare providers and individuals with actionable, clinically relevant insights, supporting earlier detection and better management of chronic diseases.

We are grateful for the opportunity to connect with industry leaders, potential partners, and the broader biotech community at this premier event. Thank you to Cyberport for their support and for providing this valuable platform to share our vision and technology with the world.

We look forward to building on the connections made at BIOHK 2024 as we continue our mission to transform healthcare through advanced AI and medical imaging.